Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Propofol

A fast-acting intravenous anaesthetic used to induce and maintain general anaesthesia and for sedation. Its properties were discovered by John Glen in the United Kingdom in 1973; it reached the operating theatre in 1986. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?Its milky white look, due to the soybean oil emulsion that makes it injectable, and how little patients remember afterwards earned it the nickname 'milk of amnesia'. In 2018 John Glen received the Lasker Award.

PropofolGo to the active ingredient →
PropofolActive ingredientPropofolCat. No. P-P217-001CAS 2078-54-8
Propofol-d17Isotopically labelledPropofol-d17Cat. No. P-P217-021CAS 1261393-54-7
Agidol 110ImpurityAgidol 110Cat. No. P-P217-037CAS 26347-98-8
GalvinolImpurityGalvinolCat. No. P-P217-040CAS 4359-97-1

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substancePropofol CRSEDQM code Y0000016Family Propofol

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.